13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)

PHASE4CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Lansoprazole (Lanton)

Oral administration of Lanzoprazole for 14 days in 25 patients with H.pylori infection

DRUG

Omeprezole (Losec)

Oral administration of Omeprazole for 14 days in 25 patients with H.pylori infection

DRUG

Pantoprazole(Controloc)

Oral administration of Pantoprazole for 14 days in 25 patients with H.pylori infection

DRUG

Esomeprazole (Nexium)

Oral administration of Esomeprazole for 14 days in 25 patients with H.pylori infection

Trial Locations (1)

49100

Rabin Medical Center, Petah Tikva

Sponsors
All Listed Sponsors
collaborator

Rabin Medical Center

OTHER

lead

Meridian Bioscience, Inc.

INDUSTRY

NCT00825630 - 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors) | Biotech Hunter | Biotech Hunter